Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

PR Newswire June 24, 2023

NVCR INVESTOR DEADLINE: NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire June 24, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

PR Newswire June 23, 2023

NOVOCURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR

PR Newswire June 23, 2023

ROSEN, A LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile June 23, 2023

INVESTOR ALERT: Berger Montague Advises NovoCure Limited (NVCR) Investors to Inquire About a Securities Fraud Class Action by August 18, 2023

Newsfile June 23, 2023

Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today

Business Wire June 23, 2023

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire June 23, 2023

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

Business Wire June 23, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile June 23, 2023

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

Business Wire June 22, 2023

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

Business Wire June 22, 2023

Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline Is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today

Business Wire June 22, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile June 22, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the Firm

Accesswire June 22, 2023

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) Investors

Business Wire June 21, 2023

EQUITY ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Business Wire June 21, 2023

NOVOCURE LIMITED (NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against NovoCure Limited

Newsfile June 21, 2023

Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against NovoCure Limited (NASDAQ: NVCR); Lead Plaintiff Deadline is August 18, 2023

Business Wire June 21, 2023

Calling all investors in NovoCure Limited (NVCR): New lawsuit lead plaintiff deadline is August 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today

PR Newswire June 21, 2023